Skip to main content
. 2022 Mar 5;23(5):2865. doi: 10.3390/ijms23052865

Table 1.

Associations between maternal body composition and HMO concentrations.

Maternal Predictor Secretor Non-Secretor Interaction
Parameter
Estimate
SE p-Value Parameter
Estimate
SE p-Value p-Value
2′FL
FM (%) 0.43 0.16 0.01 0.07 0.03 0.01 0.03
Log (FMI (kg/m2)) 6.05 3.00 0.05 1.25 0.53 0.02 0.23
Log (FM/FFM) 7.85 4.11 0.06 1.59 0.61 0.01 0.14
3′SL
Log (FM (kg)) −0.34 1.48 0.82 −7.13 3.03 0.02 0.05
FM (%) −0.04 0.08 0.66 −0.37 0.12 <0.001 0.02
Log (FMI (kg/m2)) −0.63 1.53 0.68 −5.88 2.56 0.03 0.08
Log (FM/FFM) −2.81 2.04 0.17 −8.36 2.68 <0.001 0.11
FLNH
Age −0.12 0.24 0.63 1.80 0.69 0.01 0.01
Log (Weight (kg)) 14.32 5.43 0.01 −36.11 22.83 0.12 0.04
Log (BMI (kg/m2)) 13.81 5.99 0.03 −15.11 15.95 0.35 0.10
Log (FM (kg)) 8.37 3.35 0.02 −16.06 8.88 0.08 0.01
Log (FMI (kg/m2)) 7.86 3.50 0.03 −11.22 7.82 0.16 0.03
Entire cohort
2′FL
Log (Weight (kg)) 3.63 1.52 0.02 - - - -
Log (BMI (kg/m2)) 2.37 1.04 0.03 - - - -
Log (FM (kg)) 1.68 0.61 0.01 - - - -
Log (LNH)
Log (BMI (kg/m2)) 0.73 0.27 0.01 - - - -
FFMI (kg/m2) 0.05 0.02 0.02 - - - -

Data are parameter value ± standard error of measurement (SE). When the interaction term with secretor status was present in the final model, results were broken down by secretor and non-secretor groups, whereas when the interaction term was not present in the final model, results are presented for the entire cohort. Significant p-values are indicated by bold text. 2′FL—2′-fucosyllactose; 3′SL—3′-sialyllactose; BMI—body mass index; FFMI—fat-free mass index; FLNH—fucosyllacto-N-hexaose; FM—fat mass; FM/FFM—fat mass to fat-free mass ratio; FMI—fat mass index; LNH—lacto-N-hexaose.